Position in FULC
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$449,738
-$39,555 QoQ
Shares Held
58,636
+35.5% QoQ
Ownership
0.088%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#69
of 168 holders
Holding Since
Mar 2024
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in FULC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026HSBC HOLDINGS PLC holds $964,220,373 across 121 Biotechnology names. FULC ranks #67 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
655,443 | $292,681,510 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
323,338 | $249,823,869 | |
| 3 | RPRX |
Royalty Pharma plc
|
1,544,018 | $74,066,541 | |
| 4 | INCY |
Incyte Corp
|
582,368 | $54,812,474 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
89,619 | $29,652,235 | |
| 6 | MRNA |
Moderna, Inc.
|
490,088 | $24,896,468 | |
| 7 | INSM |
INSMED Inc
|
116,456 | $19,042,883 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
227,059 | $15,469,528 |
All Filings in FULC
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $449,738 | 58,636 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $489,293 | 43,262 | Shares | Defined | 2026-03-20 | |
| 2025-09-30 | $495,015 | 53,806 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $340,807 | 49,536 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $215,887 | 74,961 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $357,007 | 75,959 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $174,983 | 49,015 | Shares | Defined | 2024-11-14 | |
| 2024-03-31 | $1,412,478 | 149,627 | Shares | Defined | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||